153 related articles for article (PubMed ID: 11053983)
1. Temozolomide in patients with high grade gliomas.
Brandes AA; Pasetto LM; Vastola F; Monfardini S
Oncology; 2000 Sep; 59(3):181-6. PubMed ID: 11053983
[TBL] [Abstract][Full Text] [Related]
2. New approaches for temozolomide therapy: use in newly diagnosed glioma.
Stupp R; Newlands E
Semin Oncol; 2001 Aug; 28(4 Suppl 13):19-23. PubMed ID: 11550135
[TBL] [Abstract][Full Text] [Related]
3. Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide.
Beauchesne P
J Clin Oncol; 2002 Jul; 20(14):3180-1; author reply 3181. PubMed ID: 12118035
[No Abstract] [Full Text] [Related]
4. Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma.
Abacioglu U; Caglar HB; Yumuk PF; Akgun Z; Atasoy BM; Sengoz M
J Neurooncol; 2011 Jul; 103(3):585-93. PubMed ID: 20878446
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide for recurrent high-grade glioma.
Macdonald DR
Semin Oncol; 2001 Aug; 28(4 Suppl 13):3-12. PubMed ID: 11550133
[TBL] [Abstract][Full Text] [Related]
6. [Temodal--an alkylating cytostatic agent. Effectiveness in patients with malignant gliomas].
Matsko MV
Vopr Onkol; 2012; 58(3):425-8. PubMed ID: 22888663
[No Abstract] [Full Text] [Related]
7. Benefits of adjuvant chemotherapy in high-grade gliomas.
DeAngelis LM
Semin Oncol; 2003 Dec; 30(6 Suppl 19):15-8. PubMed ID: 14765379
[TBL] [Abstract][Full Text] [Related]
8. The use of temozolomide in recurrent malignant gliomas.
Gaya A; Rees J; Greenstein A; Stebbing J
Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
[TBL] [Abstract][Full Text] [Related]
9. Promises and controversies in the management of low-grade glioma.
Stupp R; Baumert BG
Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
[No Abstract] [Full Text] [Related]
10. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
Kyritsis AP; Levin VA
Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
[TBL] [Abstract][Full Text] [Related]
11. Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies.
van den Bent MJ
Semin Oncol; 2003 Dec; 30(6 Suppl 19):39-44. PubMed ID: 14765384
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for the treatment of oligodendroglial tumors.
Chinot O
Semin Oncol; 2001 Aug; 28(4 Suppl 13):13-8. PubMed ID: 11550134
[TBL] [Abstract][Full Text] [Related]
15. Effects of temozolomide in malignant brain tumours.
Osoba D
Lancet; 2000 Jul; 356(9226):342. PubMed ID: 11071219
[No Abstract] [Full Text] [Related]
16. Temozolomide: Expanding its role in brain cancer.
Mrugala MM; Adair J; Kiem HP
Drugs Today (Barc); 2010 Nov; 46(11):833-46. PubMed ID: 21225022
[TBL] [Abstract][Full Text] [Related]
17. Is protracted low-dose temozolomide feasible in glioma patients?
Tosoni A; Cavallo G; Ermani M; Scopece L; Franceschi E; Ghimenton C; Gardiman M; Pasetto L; Blatt V; Brandes AA
Neurology; 2006 Feb; 66(3):427-9. PubMed ID: 16476947
[TBL] [Abstract][Full Text] [Related]
18. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
19. Future directions for temozolomide therapy.
Yung WK
Semin Oncol; 2001 Aug; 28(4 Suppl 13):43-6. PubMed ID: 11550138
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide: realizing the promise and potential.
Nagasubramanian R; Dolan ME
Curr Opin Oncol; 2003 Nov; 15(6):412-8. PubMed ID: 14624222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
